We are grateful to Dr. Al Copland and colleagues for the opportunity to share our work on Overcoming Resistance to RTK Inhibitors in Rhabdomyosarcoma with the outstanding group of 8 faculty in the Cancer Basic Science Research program at Mayo Clinic - Jacksonville. This group of highly accomplished scientists has, in a short number of years, created a highly synergistic and productive research unit with some of the most interesting work in cell & molecular signaling and tumor microenvironment work in cancer research. Charles is especially appreciative of his colleague, Al, for this invitation to present our work and share ideas on addressing key issues in rare (and sometimes not so rare) cancers. [ above right: Charles & Al ]
